With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
In an exclusive interview with Meet the Press, Treasury Secretary Scott Bessent addresses concerns of a troubled economy after a disappointing jobs report raises ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results